Cognitive Level Enhancement Through Vision Exams and Refraction
Launched by QUEEN'S UNIVERSITY, BELFAST · Jul 11, 2022
Trial Information
Current as of July 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how providing free glasses to older adults in Hyderabad, India, can improve their overall quality of life. Specifically, the study is focused on people aged 60 and older who have vision problems due to refractive errors, which means their eyesight could be improved with the right glasses. The researchers want to see if giving these glasses can help reduce falls, depression, and improve social interactions and physical activity over a three-year period. Participants will be randomly assigned to either receive the glasses or not, while also providing information about their experiences and the cultural context of the study.
To be eligible, participants need to live in the community, plan to stay in the area for the duration of the study, and have specific vision impairments that could be corrected with glasses. They should also have good cognitive function, meaning their thinking and memory skills are intact. Those with serious health issues or other causes of vision impairment won't be included. If chosen for the trial, participants can expect to wear the glasses and share their experiences, which will help researchers understand the impact of better vision on their daily lives.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria
- • 1. Community dwelling
- • 2. Residency
- • a. Participants must plan to reside in the local area for the study duration
- • 3. Presenting vision in the better eye due to uncorrected refractive error
- • 1. Impaired distance vision less than 6/18
- • 2. Near vision less than N6 at 40 cm
- • 4. Willingness
- • 1. to participate
- • 2. to be randomized
- • 3. to adhere to the protocol
- • Exclusion criteria
- • 1. Impaired baseline cognition
- • a. HMSE score less than or equal to 18
- • 2. Non-refractive causes of vision impairment
- • 3. Severely impaired mobility
- • 1. immobile
- • 2. bedridden
- • 3. wheelchair
- • 4. using walker
- • 4. Severe medical illness likely to limit the life span
- • 1. Cancer
- • 2. Heart disease
- • 3. Stroke
- • 4. HIV or AIDS
- • 5. Chronic lung disease
- • 6. Kidney disease
- • 5. Hearing loss assessment
- • 1. self-reported hearing impairment
- • 2. inability to hear
- • 3. fail in whisper test hearing screening(unable to repeat three out of six words)
About Queen's University, Belfast
Queen's University Belfast is a prestigious research institution located in Northern Ireland, renowned for its commitment to advancing knowledge and improving health outcomes through innovative clinical research. The university actively engages in a diverse range of clinical trials, focusing on translational medicine and interdisciplinary collaboration to address pressing health challenges. With a strong emphasis on ethical standards and patient safety, Queen's University Belfast leverages its state-of-the-art facilities and a team of experienced researchers to contribute to the development of new therapies and enhance the understanding of various medical conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hyderabad, Telangana, India
Patients applied
Trial Officials
Nathan G Congdon, MD, MPH
Principal Investigator
Queen's University, Belfast
Rohit C Khanna, MPH
Principal Investigator
L.V. Prasad Eye Institute
Suvarna Alladi, DM
Principal Investigator
National Institute of Mental Health and Neuro Sciences, India
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials